Annotated Medicine and Device Lists

Isoniazid + pyrazinamide + rifampicin

N/A Tablet 30 mg/ 150 mg/ 60mg Tablet 75 mg + 400 mg + 150 mg Tablet 150mg / 500 mg/ 300 mg Tablet (dispersible) 50 mg + 150 mg + 75mg Tablet (dispersible) 50 mg + 150 mg + 75 mg

This medicine is present in:

List	Section	Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018	03.02. ANTIBACTERIANOS	No observations

This medicine is present in:

List	Section	Observation
Haiti. National List of Essential Medicines	06.02.04 Anti-tuberculosis drugs	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.3. Antituberculosis med.	No observations
Mexico. Cuadro Basico de Medicamentos - 2017	06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS	No observations
Mexico. Cuadro Basico de Medicamentos - 2017	06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS	No observations
Haiti. National List of Essential Medicines	06.02.04 Anti-tuberculosis drugs	No observations

This medicine is present in:

List	Section	Observation
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021	8: 16 Antituberculosis agents	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.3. Antituberculosis med.	No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019	03. Antituberculosos	No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020	J. ANTI-INFECCIOSOS PARA USO SISTEMICO	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.2.5. Antituberculosis medicines	This medicine requires a children care specialist.

Information Resources: Isoniazid + pyrazinamide + rifampicin

No information available